Who founded Torpedo Therapeutics?

Torpedo Therapeutics was founded by Ingrid van Welie in 2018.

Who are Torpedo Therapeutics's investors?

Torpedo Therapeutics's investors include Y Combinator.

Where is Torpedo Therapeutics headquartered?

Torpedo Therapeutics is headquartered in Boston, US.

Torpedo Therapeutics

YC W22

Boston, US · Founded 2018 · 5 employees · 1 known investors

Find your way into Torpedo Therapeutics

169 people in our graph share verified history with the Torpedo Therapeutics team — schools, employers, funds. One of them is your warm intro.

Damien van der Bijlunlockedknows Ingrid van Welie · together at University of Amsterdam (overlapped)

×3knows the team · via University College London

×4knows the team · via Salk Institute for Biological Studies

×4knows the team · via University of Amsterdam

Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.

Also known as Neural Dynamics · Neural Dynamics Technologies · Neural Dynamics Technologies Inc. · Neural Dynamics Technologies LLC

AI & Machine Learning Biotech Deep Tech Healthtech Medical Devices NeurotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W22)

Torpedo Therapeutics was founded in 2018 by Ingrid van Welie.

Ingrid van Welie in 𝕏Founder and CEOIngrid van Welie holds a PhD and founded Torpedo Therapeutics, where she serves as CEO. Her background is in neuroscience and biophysics, with focus on technologies for measuring and modulating neuronal electrical activity.

Investors · 1

Y CombinatorSan Francisco · $500K

Frequently asked questions

What does Torpedo Therapeutics do?: Torpedo Therapeutics develops high-precision, closed-loop deep brain stimulation devices for treating neurological disorders including Parkinson's disease, essential tremor, dystonia, and drug-resistant epilepsy. The company uses micro- and nano-fabrication to create ultra-small electrode leads with machine learning-driven parameter adjustment to reduce side effects and improve treatment efficacy.
Who founded Torpedo Therapeutics?: Torpedo Therapeutics was founded by Ingrid van Welie in 2018.
Who are Torpedo Therapeutics's investors?: Torpedo Therapeutics's investors include Y Combinator.
Where is Torpedo Therapeutics headquartered?: Torpedo Therapeutics is headquartered in Boston, US.